JC

Jean-Marc Combette

XI Xigen Inflammation: 6 patents #2 of 4Top 50%
RS Ribovax Biotechnologies S.A.: 1 patents #4 of 14Top 30%
📍 Annemasse, FR: #15 of 167 inventorsTop 9%
Overall (All Time): #622,415 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11779628 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases Catherine Deloche 2023-10-10
11331364 Use for JNK inhibitor molecules for treatment of various diseases Catherine Deloche 2022-05-17
10967038 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases Catherine Deloche, Claire Abadie 2021-04-06
10624948 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases Catherine Deloche 2020-04-21
10596223 JNK inhibitor molecules for treatment of various diseases Catherine Deloche 2020-03-24
10098925 Protein SLURP-1 for use in the treatment of ocular diseases Catherine Deloche, Claire Abadie, Sebastien Mouz, Julien Perino 2018-10-16
9150618 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases Catherine Deloche, Claire Abadie 2015-10-06
8747856 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases Claire Abadie, Catherine Deloche, Robert Anthony Williamson 2014-06-10